News
The cannabinoid agonist market is gaining momentum due to expanding medical cannabis legalization and growing clinical validation for its use in chronic pain, epilepsy, and inflammatory conditions.
16hon MSN
Synthetic cannabinoids, a class of new psychoactive substances, have emerged as a significant public health and social stability threat due to their structural diversity, rapid iteration, and stronger ...
3d
Stockhead on MSNArgent starts EU-GMP cannabinoid supply for drug resistant epilepsy at Slovenia’s largest hospitalArgent BioPharma has started formal clinical supply of its EU-GMP cannabinoid-based active pharmaceutical ingredient (API) ...
6h
WEHT Evansville on MSNTwo arrested after EPD find over 10 pounds of drugs in vehicle with childrenTwo people were arrested after authorities say they were alerted to a large amount of synthetic cannabinoids delivered to a ...
Medical marijuana programs across Europe vary greatly but most only allow cannabis products to be dispensed through ...
Alexander Malyshev and Sarah Ganley of Carter Ledyard & Milburn LLP discuss a gray area when the 2018 Farm Bill legalized ...
As patients increasingly turn to cannabis for chronic pain, clinicians grapple with mixed evidence and a lack of high-quality ...
A powerful Senate committee has approved a bill that contains provisions hemp industry stakeholders say would devastate the ...
The senator who championed the federal legalization of hemp is now seeking to reverse much of the reform by pushing ...
Pervasive stigma around cannabis use is leading some ER doctors to overdiagnose a rare marijuana-related syndrome.
Evansville authorities say they arrested two people on dealing and neglect charges after a package containing more than 10 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results